Bladder Cancer Risk Stratification: Moving from the Old to the New
0 Views
administrator
07/08/23
Joshua J. Meeks, MD, PhD, Associate Professor of Urology, Biochemistry and Molecular Genetics at the Northwestern University Feinberg School of Medicine in Chicago, Ill, discusses nonmuscle-invasive bladder cancer (NMIBC) risk stratification. Dr. Meeks emphasizes minimal intervention in low-risk patients, the heterogeneity of the intermediate-risk category, and the risk of progression in patients in the high-risk category.
-
Category
Show more
Facebook Comments
No comments found